Fabio Nicolini

1.7k total citations
45 papers, 831 citations indexed

About

Fabio Nicolini is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Fabio Nicolini has authored 45 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Cardiology and Cardiovascular Medicine and 8 papers in Molecular Biology. Recurrent topics in Fabio Nicolini's work include CAR-T cell therapy research (7 papers), Cardiac Ischemia and Reperfusion (7 papers) and Nitric Oxide and Endothelin Effects (5 papers). Fabio Nicolini is often cited by papers focused on CAR-T cell therapy research (7 papers), Cardiac Ischemia and Reperfusion (7 papers) and Nitric Oxide and Endothelin Effects (5 papers). Fabio Nicolini collaborates with scholars based in United States, Italy and Sweden. Fabio Nicolini's co-authors include J. L. Mehta, Paulette Mehta, Krishna Vaddi, Wilmer W. Nichols, Tom Saldeen, Massimiliano Mazza, Eric J. Topol, Daniel Lawson, Kandice Kottke‐Marchant and Martine Bocchini and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Biochemical and Biophysical Research Communications.

In The Last Decade

Fabio Nicolini

44 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabio Nicolini United States 16 260 171 139 138 133 45 831
Martin F. Reiner Switzerland 17 128 0.5× 152 0.9× 123 0.9× 51 0.4× 94 0.7× 47 697
Stefania Momi Italy 18 283 1.1× 166 1.0× 56 0.4× 316 2.3× 137 1.0× 25 957
Jonghyeon Kim United States 17 79 0.3× 208 1.2× 95 0.7× 175 1.3× 141 1.1× 28 1.4k
Masuhiro Yoshitake United States 13 383 1.5× 285 1.7× 41 0.3× 128 0.9× 53 0.4× 20 911
Jean‐Marc Herbert France 18 426 1.6× 403 2.4× 94 0.7× 127 0.9× 114 0.9× 37 1.2k
Jae Kyeong Byun South Korea 15 188 0.7× 216 1.3× 72 0.5× 35 0.3× 187 1.4× 52 742
Trine B. Opstad Norway 19 218 0.8× 229 1.3× 55 0.4× 70 0.5× 285 2.1× 55 808
Seung Hee Lee South Korea 10 99 0.4× 294 1.7× 71 0.5× 89 0.6× 100 0.8× 19 832
Jasmina Markovic‐Lipkovski Serbia 18 98 0.4× 294 1.7× 87 0.6× 42 0.3× 213 1.6× 61 1.1k
Gabriella Passacquale United Kingdom 15 291 1.1× 152 0.9× 77 0.6× 100 0.7× 124 0.9× 22 743

Countries citing papers authored by Fabio Nicolini

Since Specialization
Citations

This map shows the geographic impact of Fabio Nicolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Nicolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Nicolini more than expected).

Fields of papers citing papers by Fabio Nicolini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Nicolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Nicolini. The network helps show where Fabio Nicolini may publish in the future.

Co-authorship network of co-authors of Fabio Nicolini

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Nicolini. A scholar is included among the top collaborators of Fabio Nicolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Nicolini. Fabio Nicolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nicolini, Fabio, Roberta Maltoni, Matteo Marchesini, et al.. (2024). Significant Advancements and Evolutions in Chimeric Antigen Receptor Design. International Journal of Molecular Sciences. 25(22). 12201–12201. 4 indexed citations
3.
4.
Calabrò, Luana, Giuseppe Bronte, Federica Grosso, et al.. (2024). Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream. Frontiers in Immunology. 14. 1333661–1333661. 3 indexed citations
5.
Martino, Massimo, Gaetana Porto, Giuseppe Console, et al.. (2023). The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic. Supportive Care in Cancer. 31(6). 350–350. 2 indexed citations
6.
Bocchini, Martine, Marcella Tazzari, Sara Ravaioli, et al.. (2023). Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors. Frontiers in Oncology. 13. 1136331–1136331. 4 indexed citations
7.
Martino, Massimo, Caterina Alati, Iolanda Donatella Vincelli, et al.. (2021). CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma. Cancers. 13(11). 2639–2639. 23 indexed citations
8.
Nicolini, Fabio, Sara Bravaccini, Massimiliano Mazza, et al.. (2021). CAR T cells targeting options in the fight against multiple myeloma. Panminerva Medica. 63(1). 37–45. 5 indexed citations
9.
Nicolini, Fabio, Olga Burmistrova, Fernando Torres, et al.. (2013). Induction of G2/M phase arrest and apoptosis by the flavonoid tamarixetin on human leukemia cells. Molecular Carcinogenesis. 53(12). 939–950. 46 indexed citations
10.
Silver, Mitchell, et al.. (1998). Use of a novel anti-apoptotic agent (LXR017) reduces infarct size following ischemia-reperfusion in the canine myocardium. Journal of the American College of Cardiology. 31. 66–66. 1 indexed citations
11.
Yang, Baichun, Fabio Nicolini, Wilmer W. Nichols, & Jawahar L. Mehta. (1994). Failure of brief ischemic episodes to protect against myocardial dysfunction caused by ischemia and reperfusion in isolated rat hearts. American Heart Journal. 128(6). 1192–1200. 7 indexed citations
12.
Nichols, Wilmer W., et al.. (1994). Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion. American Heart Journal. 127(5). 1201–1211. 12 indexed citations
13.
Mehta, J. L., Wilmer W. Nichols, Fabio Nicolini, et al.. (1994). Neutrophil elastase inhibitor ICI 200,880 protects against attenuation of coronary flow reserve and myocardial dysfunction following temporary coronary artery occlusion in the dog. Cardiovascular Research. 28(7). 947–956. 16 indexed citations
14.
Nichols, Wilmer W., Fabio Nicolini, Saeed R. Khan, Tom Saldeen, & J. L. Mehta. (1993). Failure of prostacyclin analog iloprost to sustain coronary blood flow after recombinant tissue-type plasminogen-induced thrombolysis in dogs. American Heart Journal. 126(2). 285–292. 7 indexed citations
15.
Mehta, J. L., et al.. (1992). Variable effects of human and canine polymorphonuclear leucocytes on vascular smooth muscle tone. Cardiovascular Research. 26(8). 751–756. 12 indexed citations
16.
Nichols, Wilmer W., Fabio Nicolini, Tom Saldeen, & J. L. Mehta. (1991). Combined Thrombolytic Effects of Tissue-Plasminogen Activator and a Fibrinogen-Degradation Product Peptide 6A or Iloprost. Journal of Cardiovascular Pharmacology. 18(2). 231–236. 4 indexed citations
17.
Mehta, J, et al.. (1990). Sulfhydryl Group in Angiotensin Converting Enzyme Inhibitors and Superoxide Radical Formation. Journal of Cardiovascular Pharmacology. 16(5). 847–849. 16 indexed citations
18.
Nicolini, Fabio, Paulette Mehta, Daniel Lawson, & J. L. Mehta. (1990). Reduction in human neutrophil chemotaxis by the prostacyclin analogue iloprost. Thrombosis Research. 59(3). 669–674. 14 indexed citations
19.
Mehta, J. L., et al.. (1990). Evidence for generation of a large amount of nitric oxide-like vascular smooth muscle relaxant by cholesterol-rich neutrophils. Biochemical and Biophysical Research Communications. 173(1). 438–442. 10 indexed citations
20.
Nicolini, Fabio & J. L. Mehta. (1990). Iloprost and tissue-type plasminogen activator differently affect platelet aggregation in platelet-rich plasma and in whole blood. Thrombosis Research. 60(5). 337–342. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin F. Reiner Breakdown of academic impact, for papers by Stefania Momi Breakdown of academic impact, for papers by Jonghyeon Kim Breakdown of academic impact, for papers by Masuhiro Yoshitake Breakdown of academic impact, for papers by Jean‐Marc Herbert Breakdown of academic impact, for papers by Jae Kyeong Byun Breakdown of academic impact, for papers by Trine B. Opstad Breakdown of academic impact, for papers by Seung Hee Lee Breakdown of academic impact, for papers by Jasmina Markovic‐Lipkovski Breakdown of academic impact, for papers by Gabriella Passacquale
Rankless by CCL
2026